HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshifumi Takeyama Selected Research

Acute Hemorrhagic Pancreatitis

4/2006Pancreatic and bile duct obstruction exacerbates rat caerulein-induced pancreatitis: a new experimental model of acute hemorrhagic pancreatitis.
1/2002Hematin is one of the cytotoxic factors in pancreatitis-associated ascitic fluid that causes hepatocellular injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshifumi Takeyama Research Topics

Disease

37Pancreatitis
10/2022 - 01/2002
18Neoplasms (Cancer)
08/2022 - 01/2002
8Pancreatic Fistula (Pancreatic Fistulas)
08/2022 - 02/2002
8Neoplasm Metastasis (Metastasis)
01/2020 - 04/2010
8Pancreatic Neoplasms (Pancreatic Cancer)
11/2017 - 07/2002
7Acute Necrotizing Pancreatitis
03/2020 - 06/2006
7Infections
01/2009 - 02/2006
6Carcinoma (Carcinomatosis)
04/2020 - 07/2002
6Stomach Neoplasms (Stomach Cancer)
12/2014 - 01/2012
4Inflammation (Inflammations)
01/2013 - 08/2006
3Wounds and Injuries (Trauma)
01/2019 - 01/2002
3Disease Progression
04/2018 - 08/2006
3Lymphatic Metastasis
11/2017 - 01/2013
3Ascites
01/2013 - 04/2007
3Gallstones (Gallstone)
01/2010 - 05/2004
2Pathologic Constriction (Stenosis)
05/2022 - 01/2010
2Necrosis
06/2020 - 01/2010
2Hemorrhage
01/2020 - 06/2006
2Duodenal Neoplasms (Duodenal Cancer)
01/2020 - 01/2013
2Jaundice (Icterus)
04/2018 - 09/2004
2Autoimmune Pancreatitis
04/2018 - 08/2017
2Shock
01/2018 - 02/2016
2Pancreatic Pseudocyst
02/2016 - 01/2010
2Pain (Aches)
06/2015 - 06/2006
2Lymphoma (Lymphomas)
03/2015 - 10/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2015 - 10/2014
2Colorectal Neoplasms (Colorectal Cancer)
11/2011 - 08/2002
2Cholestasis
01/2010 - 04/2006
2Lithiasis
01/2010 - 01/2008
2Acute Hemorrhagic Pancreatitis
04/2006 - 01/2002
2Anastomotic Leak
01/2003 - 09/2002
1Pancreatic Diseases (Pancreatic Disease)
08/2022
1Steatorrhea
05/2022
1Non-alcoholic Fatty Liver Disease
04/2022
1Body Weight (Weight, Body)
01/2022
1Hypoglycemia (Reactive Hypoglycemia)
01/2022
1Insulin Resistance
01/2021
1Gallbladder Neoplasms (Gallbladder Cancer)
04/2020

Drug/Important Bio-Agent (IBA)

9Anti-Bacterial Agents (Antibiotics)IBA
10/2022 - 06/2006
7Proteins (Proteins, Gene)FDA Link
01/2009 - 07/2002
5Protease Inhibitors (Protease Inhibitor)IBA
03/2020 - 06/2006
5Deoxycholic Acid (Sodium Deoxycholate)IBA
05/2010 - 02/2002
4CholesterolIBA
01/2022 - 01/2003
4EndotoxinsIBA
01/2010 - 09/2004
3Biological ProductsIBA
04/2017 - 07/2002
3AmylasesFDA Link
01/2017 - 04/2006
3Messenger RNA (mRNA)IBA
02/2016 - 08/2002
3Paclitaxel (Taxol)FDA LinkGeneric
12/2012 - 01/2012
3OsteopontinIBA
11/2011 - 01/2009
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2007 - 06/2006
3ImmunosorbentsIBA
06/2006 - 05/2002
3EnzymesIBA
06/2006 - 05/2002
3salicylhydroxamic acid (SHAM)IBA
09/2004 - 02/2002
2Glucose (Dextrose)FDA LinkGeneric
05/2022 - 09/2018
2Hypoglycemic Agents (Hypoglycemics)IBA
01/2022 - 02/2016
2GemcitabineFDA Link
04/2020 - 01/2006
2Analgesics (Analgesic Drugs)IBA
03/2020 - 01/2010
2Polyglactin 910IBA
11/2019 - 01/2016
2SteroidsIBA
04/2018 - 08/2017
2Tumor Biomarkers (Tumor Markers)IBA
11/2017 - 11/2007
2Phosphotransferases (Kinase)IBA
03/2015 - 10/2014
2CrizotinibIBA
03/2015 - 10/2014
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
03/2015 - 10/2014
2Monoclonal AntibodiesIBA
12/2013 - 12/2012
2Bile Acids and Salts (Bile Acids)IBA
01/2013 - 11/2004
2Triggering Receptor Expressed on Myeloid Cells-1IBA
05/2010 - 07/2008
2Glycoproteins (Glycoprotein)IBA
01/2010 - 01/2008
2Thromboplastin (Tissue Factor)IBA
01/2009 - 06/2006
2Toll-Like Receptor 2IBA
11/2008 - 01/2007
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2007 - 08/2006
2HMGB1 Protein (HMG1)IBA
12/2006 - 11/2006
2CeruletideIBA
04/2006 - 11/2004
1N-succinimidyl 3-(2-pyridyldithio)propionate (SPDP)IBA
08/2022
1Short-Acting InsulinIBA
01/2022
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2022
1Cisplatin (Platino)FDA LinkGeneric
04/2020
1nafamostatIBA
03/2020
1Therapeutic UsesIBA
01/2020
1ThrombomodulinIBA
01/2020

Therapy/Procedure

10Pancreatectomy
08/2022 - 09/2002
7Enteral Nutrition (Feeding, Tube)
10/2022 - 06/2006
7Pancreaticoduodenectomy
08/2022 - 02/2002
6Drug Therapy (Chemotherapy)
04/2020 - 01/2012
6Therapeutics
03/2020 - 08/2007
4Intra-Arterial Infusions
03/2020 - 06/2006
3Intravenous Administration
03/2020 - 06/2006
3Sutures (Suture)
11/2019 - 02/2002
3Stents
04/2018 - 01/2013
3Lymph Node Excision (Lymph Node Dissection)
12/2012 - 01/2002
2Operative Surgical Procedures
05/2022 - 01/2010
2Pancreaticojejunostomy
05/2022 - 09/2002
2Glycemic Control
01/2022 - 09/2018
2Length of Stay
01/2021 - 05/2019
2Laparoscopic Cholecystectomy
01/2019 - 05/2004
2Lithotripsy (Extracorporeal Shockwave Lithotripsy)
01/2018 - 02/2016
2Critical Care (Surgical Intensive Care)
06/2015 - 01/2010
2Gastrectomy
12/2012 - 01/2012
2Intraperitoneal Injections
04/2010 - 01/2002
2Cholecystectomy
10/2009 - 01/2002
2Ligation
04/2006 - 09/2003